Indian Red Cross Society join hands with Cadila Pharmaceuticals to launch ambitious project of training 50000 students for CPR and First Aid Training

Pharma Giant partners with Indian Red Cross to administer life-saving training

Ahmedabad, 29^th January 2024: Cadila Pharmaceuticals, a pioneer and one of the largest privately held Pharmaceutical companies in the country, has initiated a Cardiopulmonary Resuscitation (CPR) and First Aid training program in collaboration with the Indian Red Cross Society, Gujarat State branch. *The ambitious project aims to train 50,000 students in Ahmedabad and Mehsana to equip them with essential life-saving skills.*

The program was launched at Adarsh Gyan Sagar School, Kadi, on January 25th, training over 3000 students through practical demonstrations and sessions during the launch. Notable dignitaries gracing the event were Mr. Vinodbhai Patel, Chairman of Mehsana District Cooperative Bank; Mr. Dharmesh Shah, Provost of Indrashil University; and Representatives Mr. Nareshbhai and Ms. Manishaben Solanki from the Indian Red Cross Society, Gujarat State Branch.

Scheduled to run until March 2024, the initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state. *Cadila Pharmaceuticals is committed to creating awareness and ensuring that citizens of tomorrow, students in their formative years from classes 9 to 12 are well equipped to respond effectively in emergencies, potentially saving lives.*

Dr. Bharat Champaneria, Trustee at Indrashil Kaka-Ba and Kala Budh Public Charitable Trust, the charitable arm of Cadila Pharmaceuticals, said, “The incidents of Heart attack and cardiac arrest have increased alarmingly in the state, posing a threat to the lives irrespective of the age bar. We are aligning our efforts with the government of Gujarat’s objectives and aim for a significant contribution to community well-being. *Even if a single life is saved because of this initiative, we will consider it a success.* In addition to life-saving skills, students will receive career orientation and guidance through Indrashil University”.

This initiative reflects Cadila Pharmaceuticals’ dedication to community health and its collaboration with esteemed organizations to create a lasting impact on the well-being of the people.

About Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve the society & community at large, has led to several world-first breakthroughs.